Partial seizures are the most common seizure type in children. New antiepileptic drugs are needed because current treatments are often inadequate, or have intolerable adverse effects. Levetiracetam ...

Credit: Shutterstock. Supernus announced that the FDA has approved the supplemental New Drug Application for Oxtellar XR (oxcarbazepine) to include monotherapy use for the treatment of partial-onset ...

Eisai announced that the FDA has approved Fycompa (perampanel tablets) as an adjunctive treatment for partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy ...

Research Triangle Park, NC (January 20, 2002) – GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) granted marketing clearance for Lamictal® (lamotrigine) Tablets as ...

Ezogabine: A New Drug for Seizure Control Phase 3 Results and Mechanism of Action Tolerability and Pharmacokinetics New Drugs in the Pipeline and Conclusions References Martin Brodie, MD, Professor of ...

Forbes contributors publish independent expert analyses and insights. I focus on new drugs and innovations in medical devices. Last week, the FDA approved XCOPRI (cenobamate tablets) to treat ...

This review contrasts the standard of care for focal epilepsy with the complex reality of managing non-lesional and ...

Patients with refractory partial and secondarily generalized seizures had a reduction in seizures after deep brain stimulation, according to new research. This multi-center clinical trial determined ...